瘤抑制剂let-7作为一个关键调节器,用于Muse细胞中的多能性基因表达
Gen Li1, Shohei Wakao2, Masaaki Kitada3,4
1Department of Stem Cell Biology and Histology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan. gen.li.e6@tohoku.ac.jp.
Cellular and molecular life sciences : CMLS
|January 23, 2024
概括
慕斯细胞使用瘤抑制器微RNA (miRNA) let-7维持多能性,而不是LIN28. 这个系统通过调节关键的基因和途径来平衡多能性与非瘤性.
科学领域:
- 干细胞生物学 干细胞生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症研究 癌症研究
背景情况:
- 胚胎干细胞 (ESC) 和诱导多能干细胞 (iPSC) 的多能性依赖于LIN28和let-7.
- 斯细胞是各种组织中发现的非瘤原生,多能性类似的干细胞.
研究的目的:
- 研究let-7和LIN28在Muse细胞多能性和非瘤性中的作用.
- 阐明了斯细胞自我更新和分化背后的分子机制.
主要方法:
- 在Muse细胞中的let-7和LIN28表达的分析.
- 研究let-7对PI3K-AKT和MEK/ERK通路的影响.
- 评估多能性基因表达 (KLF4,POU5F1,SOX2,NANOG) 和细胞过程,如增殖和衰老.
主要成果:
- 慕斯细胞表达高水平的let-7并且缺乏LIN28.
- let-7抑制PI3K-AKT通路,维持多能性基因表达并抑制增殖/糖解.
- MEK/ERK路径独立于let-7,可能调节自我更新和衰老抑制.
结论:
- 慕斯细胞利用一个独特的系统,其中瘤抑制剂let-7,而不是LIN28,调节多能性基因.
- 这种以let-7为中心的机制赋予了类似于多能性的特征,同时最大限度地降低了瘤性风险.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Maintenance of the ES Cell State
2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K


